Related Experiment Video
Updated: Jun 4, 2025

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
Published on: October 25, 2016
Microglia-Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the
Yan Kong1,2, Xian Zhang1, Ling Li1
1Department of Neurology in Affiliated Zhongda Hospital and Jiangsu Provincial Medical Key Discipline, School of Medicine, Institute of Neuropsychiatry, Key Laboratory of Developmental Genes and Human Disease in Ministry of Education, Southeast University, Nanjing, 210096, China.
Abstract:
Vitamin D binding protein (VDBP) is a potential biomarker of major depressive disorder (MDD). This study demonstrates for the first time that VDBP is highly expressed in core emotion-related brain regions of mice susceptible to chronic unpredictable mild stress (CUMS). Specifically, the overexpression of microglia (MG)-derived VDBP in the prelimbic leads to depression-like behavior and aggravates CUMS-induced depressive phenotypes in mice, whereas conditional knockout of MG-derived VDBP can reverse both neuronal damage and depression-like behaviors. Mechanistically, the binding of MG-derived VDBP with the neuronal receptor megalin mediates the downstream SRC signaling pathway, leading to neuronal and synaptic damage and depression-like behaviors. These events may be caused by biased activation of inhibitory neurons and excitatory-inhibitory imbalance. Importantly, this study has effectively identified MG-derived VDBP as a pivotal mediator in the interplay between microglia and neurons via its interaction with the neuronal receptor megalin and intricate downstream impacts on neuronal functions, thus offering a promising therapeutic target for MDD.
Insights
Vitamin D binding protein (VDBP) from microglia drives depression-like behaviors by damaging neurons. Targeting this VDBP offers a new therapeutic strategy for major depressive disorder (MDD).
Area of Science:
- Neuroscience
- Psychiatry
- Molecular Biology
Background:
- Major depressive disorder (MDD) lacks definitive biomarkers.
- Vitamin D binding protein (VDBP) is implicated as a potential MDD biomarker.
- The role of VDBP in the neurobiology of depression is not fully understood.
Purpose of the Study:
- To investigate the role of microglia-derived VDBP in depression-like behaviors.
- To elucidate the molecular mechanisms linking VDBP to neuronal damage in MDD.
- To identify VDBP as a potential therapeutic target for MDD.
Main Methods:
- Utilized a chronic unpredictable mild stress (CUMS) mouse model.
- Examined VDBP expression in brain regions related to emotion.
- Employed conditional knockout strategies for microglia-derived VDBP.
- Investigated the interaction between VDBP, megalin, and the SRC signaling pathway.
Main Results:
- VDBP is highly expressed in emotion-related brain regions in CUMS mice.
- Overexpression of microglia-derived VDBP induced depression-like behaviors and neuronal damage.
- Conditional knockout of microglia-derived VDBP reversed these effects.
- VDBP binding to megalin activated SRC signaling, causing neuronal and synaptic damage.
Conclusions:
- Microglia-derived VDBP is a key mediator in MDD pathogenesis.
- The VDBP-megalin-SRC pathway contributes to neuronal damage and depression-like behaviors.
- Targeting microglia-derived VDBP presents a promising therapeutic avenue for MDD.
Related Concept Videos
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
G-protein Coupled Receptors
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

